Protease inhibitors
    3.
    发明授权
    Protease inhibitors 失效
    蛋白酶抑制剂

    公开(公告)号:US07071184B2

    公开(公告)日:2006-07-04

    申请号:US10239343

    申请日:2001-03-07

    摘要: The present invention provides C1-6alkyl-4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease; and parasitic diseases, including malaria, by administering to a patient in need thereof one or more compounds of the present invention.

    摘要翻译: 本发明提供C 1-6烷基-4-氨基 - 氮杂-3-酮蛋白酶抑制剂及其药学上可接受的盐,水合物和溶剂合物,其抑制蛋白酶,包括组织蛋白酶K,这些化合物的药物组合物 ,这种化合物的新型中间体,以及用于治疗过度骨丢失或软骨或基质降解(包括骨质疏松症)的疾病的方法; 牙龈疾病包括牙龈炎和牙周炎; 关节炎,更具体地,骨关节炎和类风湿性关节炎; 佩吉特病 恶性高钙血症; 和代谢性骨病; 和寄生虫病,包括疟疾,通过向有需要的患者施用一种或多种本发明的化合物。